Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New trial helps reshape the future of recovery research for critically ill patients

13

Jul 2026

New trial helps reshape the future of recovery research for critically ill patients

A new national clinical trial, funded by the National Institutes of Health, is helping reshape the future of recovery research for critically ill patients, providing important new evidence about how rehabilitation and nutrition interventions should be delivered during severe illness and informing the next generation of research to improve ICU survivors' outcomes.

GLP-1 weight loss may reduce first-impression penalties in relationships and hiring

13

Jul 2026

GLP-1 weight loss may reduce first-impression penalties in relationships and hiring

An NBER working paper found that GLP-1 initiation and associated weight loss were followed by higher partnership formation among initially single women and greater employment entry among women who were not employed. The findings suggest that part of the female obesity penalty may arise when prospective partners and employers form first impressions, although the observational analysis did not directly prove discrimination

AI errors shaped doctors’ judgments despite contradictory evidence

13

Jul 2026

AI errors shaped doctors’ judgments despite contradictory evidence

Two experiments involving 223 self-reported physicians found that incorrect AI patient classifications strongly influenced treatment decisions and effectiveness judgments. Even when patient outcomes contradicted the AI, participants struggled to revise their conclusions and, in one experiment, judged a completely ineffective treatment as beneficial.

Study: Bariatric surgery is safe, effective for obese adolescents and young adults

13

Jul 2026

Study: Bariatric surgery is safe, effective for obese adolescents and young adults

A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute demonstrates that metabolic and bariatric surgery can be delivered safely and effectively for adolescents and young adults living with severe obesity, offering promising improvements in weight loss and obesity-related health conditions.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.